Amedisys Inc
XBER:ADY
Amedisys Inc
XBER:ADY
Price:
85.5
EUR
-0.58%
Market Closed
Market Cap:
€4.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Amedisys Inc
XBER:ADY
|
US |
|
E
|
Eiffage SA
XBER:EF3
|
FR |
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
AU |
|
D
|
Delta Air Lines Inc
XMUN:OYC
|
US |
|
B
|
Beigene Ltd
XMUN:49B
|
KY |
|
L
|
Linde PLC
F:LIN
|
UK |
|
Beigene Ltd
F:49B
|
KY |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
|
H
|
Heritage Distilling Holding Company Inc
NASDAQ:IPST
|
US |
|
C
|
Close Brothers Group PLC
OTC:CBGPF
|
UK |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADY's stock price target?
Not Available
ADY does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Amedisys Inc?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Amedisys Inc?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Amedisys Inc?
Projected CAGR
58%
58%
The compound annual growth rate for Net Income over the next 3 years is 58%.
